OBJECTIVES: Little is known about relevant events in the at-risk phase of rheumatoid arthritis before the development of clinically apparent inflammatory arthritis (IA). The present study assessed musculoskeletal symptoms, infections and comorbidity in future IA patients. METHODS: In a nested case-control study using electronic health records of general practitioners, the frequency and timing of 192 symptoms or diseases were evaluated before a diagnosis of IA, using the International Classification of Primary Care coding system. Cases were 2314 adults with a new diagnosis IA between 2012 and 2016; controls were matched 1:2. The frequency of primary care visits was compared using logistic regression. RESULTS: The frequency of visits for musc...
Background: Rheumatoid arthritis (RA) has articular and non-articular manifestations. Early, intensi...
Objective: Patients with inflammatory arthritis (IA) have an increased risk of cardiovascular diseas...
Objectives: To monitor progression to inflammatory arthritis (IA) in individuals with non-specific m...
Objectives Little is known about relevant events in the at risk phase of rheumatoid arthritis befor...
Objectives Little is known about relevant events in the at-risk phase of rheumatoid arthritis before...
Background & Aim: Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by cli...
Objective.: Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) p...
Background: To explore the prevalence of chronic diseases at the onset of inflammatory arthritis (IA...
Background: Studies determining the development of a wide variety of different comorbid disorders in...
Objective. Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) pa...
OBJECTIVES: To describe the prevalence of self-reported inflammatory joint symptoms, such as joint p...
Objectives: To describe the prevalence of self-reported inflammatory joint symptoms, such as joint p...
Background: Studies determining the development of a wide variety of different comorbid disorders in...
Objective. Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) pa...
Background: The increased mortality observed in patients with rheumatoid arthritis is partly due to ...
Background: Rheumatoid arthritis (RA) has articular and non-articular manifestations. Early, intensi...
Objective: Patients with inflammatory arthritis (IA) have an increased risk of cardiovascular diseas...
Objectives: To monitor progression to inflammatory arthritis (IA) in individuals with non-specific m...
Objectives Little is known about relevant events in the at risk phase of rheumatoid arthritis befor...
Objectives Little is known about relevant events in the at-risk phase of rheumatoid arthritis before...
Background & Aim: Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by cli...
Objective.: Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) p...
Background: To explore the prevalence of chronic diseases at the onset of inflammatory arthritis (IA...
Background: Studies determining the development of a wide variety of different comorbid disorders in...
Objective. Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) pa...
OBJECTIVES: To describe the prevalence of self-reported inflammatory joint symptoms, such as joint p...
Objectives: To describe the prevalence of self-reported inflammatory joint symptoms, such as joint p...
Background: Studies determining the development of a wide variety of different comorbid disorders in...
Objective. Little is known about the presence of chronic morbidity in inflammatory arthritis (IA) pa...
Background: The increased mortality observed in patients with rheumatoid arthritis is partly due to ...
Background: Rheumatoid arthritis (RA) has articular and non-articular manifestations. Early, intensi...
Objective: Patients with inflammatory arthritis (IA) have an increased risk of cardiovascular diseas...
Objectives: To monitor progression to inflammatory arthritis (IA) in individuals with non-specific m...